The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.

The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. [electronic resource] - JAMA Nov 1973 - 652-7 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0098-7484


Adult
Anticholesteremic Agents--therapeutic use
Clinical Trials as Topic
Clofibrate--therapeutic use
Coronary Disease--drug therapy
Dextrothyroxine--therapeutic use
Drug Evaluation
Drug Therapy, Combination
Estrogens, Conjugated (USP)--administration & dosage
Follow-Up Studies
Humans
Lipoproteins, LDL--blood
Lipoproteins, VLDL--blood
Male
Middle Aged
Myocardial Infarction--diagnosis
Nicotinic Acids--therapeutic use
Placebos
Recurrence
Sodium
Time Factors